Medical Properties Trust faces slow recovery amid tenant bankruptcies, impairments, and economic headwinds. Read the latest ...

Discover Alibaba's AI pivot, profitability, and valuation advantages. Explore its contrarian opportunity amid improving ...

Snap recently corrected by ~15% after Q2 2025 results; it's user and subscription growth is positive. Click here to find out ...

Viking Holdings shows strong growth and premium pricing power in luxury cruises, but high valuation and cyclical risks warrant caution. See why VIK stock is a hold.

In the first quarter, the Lazard US Convertible Portfolio outperformed its benchmark, the ICE BofA All US Convertibles Index.

ULTY targets high income with active, quant-driven options strategies and has improved payouts and downside protection in ...

Alluvial Capital spotlights ContextLogic’s cash-rich NOL shell and dealflow with BC Partners. See why this setup could unlock ...

Monday announced the acquisition of a fully operational 50 MW mining facility in Georgia for a total cash consideration of ...

Tesla's $29B Musk pay plan may push earnings negative, risking investor exits amid falling sales, rising costs, and subsidy ...

lululemon is a world-famous athletic apparel company trading at an incredibly attractive valuation. For instance, its forward ...

Discover how Synopsys is strengthening its EDA market leadership post-Ansys merger while expanding its portfolio.

Ginkgo Bioworks rallied on a Q2 beat but slashed guidance, posted large losses, and announced a $500M shelf amid cash burn. Find out why DNA stock is a sell.